Article Details
Retrieved on: 2023-11-21 17:27:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The pharma will pay as much as $610 million to buy the five-year-old startup, which is working on an ion channel target Merck's previously pursued ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here